Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
American Journal of Blood Research|July 15, 2015
PNH is a debilitating, fatal but treatable disease: same disease, different clinical presentationsFahri Sahin, Asu F Yilmaz, Melda Comert Ozkan, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 19, 2020
Ruxolitinib Regulates the Autophagy Machinery in Multiple Myeloma CellsAlican Kusoglu, Bakiye G Bagca, Neslihan P O Ay, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|February 17, 2015
Can an oral antidiabetic (rosiglitazone) be of benefit in leukemia treatment?Sevki Cetinkalp, Ilgın Yildirim Simsir, Fahri Sahin, et al.
Current Controlled Trials in Cardiovascular Medicine|March 1, 2005
Presence of factors that activate platelet aggregation in mitral stenotic patients' plasmaIstemihan Tengiz, Ertugrul Ercan, Fahri Sahin, et al.
Hematology (Amsterdam, Netherlands)|June 19, 2010
Gossypol exerts its cytotoxic effect on HL-60 leukemic cell line via decreasing activity of protein phosphatase 2A and interacting with human telomerase reverse transcriptase activityFahri Sahin, Cigir Biray Avci, Cumhur Gunduz, et al.
Hematology (Amsterdam, Netherlands)|September 18, 2008
The interaction between taxoids and serine/threonine protein phosphatase activities during taxan-induced apoptosis of HL 60 leukemic cellsFahri Sahin, Handan Ak Celik, Hakan Hikmet Aydin, et al.
International Urology and Nephrology|June 13, 2020
A histopathological scoring and grading system to predict outcome for patients with AA amyloidosisAygul Celtik, Sait Sen, Fatma Keklik, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 23, 2017
Risk factors for poor mobilization in solid tumors: How effectively can we mobilize patients with solid tumors?Fergun Yilmaz, Nur Soyer, Ruchan Uslu, et al.
Archives of Pharmacal Research|September 7, 2002
Which dosing scheme is suitable for the taxanes? An in vitro modelUlus All Sanli, Ruchan Uslu, Bulent Karabulut, et al.
Leukemia Research|February 13, 2002
Arsenic trioxide and methylprednisolone use different signal transduction pathways in leukemic differentiationSafak Yuksel, Guray Saydam, Ruchan Uslu, et al.
Pageof 8